Clinical value of transcervical resection under hysteroscope for placental remnants
To study the clinical value of transcervical resection under hysteroscope in treatment of placental remnants. From March 2003 to April 2006, 14 cases of placental remnants were treated with transcervical resection under hysteroscope. They included 3 cases of term birth, and 11 cases of midtrimester...
Gespeichert in:
| Veröffentlicht in: | Chung-hua fu chʿan kʿo tsa chih 2007-08, Vol.42 (8), p.523-525 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | chi |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 525 |
|---|---|
| container_issue | 8 |
| container_start_page | 523 |
| container_title | Chung-hua fu chʿan kʿo tsa chih |
| container_volume | 42 |
| creator | Mu, Yu-lan Liu, Ming Li, Qiang Yang, Zhong-li Yin, Fu-bo |
| description | To study the clinical value of transcervical resection under hysteroscope in treatment of placental remnants.
From March 2003 to April 2006, 14 cases of placental remnants were treated with transcervical resection under hysteroscope. They included 3 cases of term birth, and 11 cases of midtrimester induction of labor. Drug pretreatment was performed for those who had more than 80 U/L of blood beta-human chorionic gonadotropin (beta-hCG) level, including mifepristone (RU486), Chinese herbs and methotrexate (MTX). RU486 was taken orally at 25 mg, three times daily and misoprostol was given 600 microg at one dose on the third day. MTX was given by deep intramuscular injection at 1 mg/m(2) if beta-hCG was higher than 150 U/L. Bipolar evaporation was used in the operation with alternation of resection and forceps holder under ultrasonographic supervision. After operation a circular contraceptive device was placed followed by hormone periodic treatment such as estradiol valerate for 2 - 4 months.
Under the monitori |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_68481224</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68481224</sourcerecordid><originalsourceid>FETCH-LOGICAL-p124t-80759c1cce1b8c8733bd39717362499d42bd6c1b6902edae8925c922f74fcdaa3</originalsourceid><addsrcrecordid>eNo1kEtLAzEYRbNQbKn9C5KVu4HJY_JYSvEFBRcquBvy-AYHMsmYZAr995ZaVxcuh8PlXqF121HddEJ-rdC2lNG2HWFCUaJv0IpIrRhXeo3ed2GMozMBH0xYAKcB12xicZAP5zpDAVfHFPESPWT8fSwVciouzYCHlPEcjINYz-gUTazlFl0PJhTYXnKDPp8eP3Yvzf7t-XX3sG9mQnltVCs77YhzQKxySjJmPdOSSCYo19pzar1wxArdUvAGlKad05QOkg_OG8M26P7PO-f0s0Cp_TSehodgIqSl9EJxRSjlJ_DuAi52At_PeZxMPvb_N7BfDTpazw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68481224</pqid></control><display><type>article</type><title>Clinical value of transcervical resection under hysteroscope for placental remnants</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Mu, Yu-lan ; Liu, Ming ; Li, Qiang ; Yang, Zhong-li ; Yin, Fu-bo</creator><creatorcontrib>Mu, Yu-lan ; Liu, Ming ; Li, Qiang ; Yang, Zhong-li ; Yin, Fu-bo</creatorcontrib><description>To study the clinical value of transcervical resection under hysteroscope in treatment of placental remnants.
From March 2003 to April 2006, 14 cases of placental remnants were treated with transcervical resection under hysteroscope. They included 3 cases of term birth, and 11 cases of midtrimester induction of labor. Drug pretreatment was performed for those who had more than 80 U/L of blood beta-human chorionic gonadotropin (beta-hCG) level, including mifepristone (RU486), Chinese herbs and methotrexate (MTX). RU486 was taken orally at 25 mg, three times daily and misoprostol was given 600 microg at one dose on the third day. MTX was given by deep intramuscular injection at 1 mg/m(2) if beta-hCG was higher than 150 U/L. Bipolar evaporation was used in the operation with alternation of resection and forceps holder under ultrasonographic supervision. After operation a circular contraceptive device was placed followed by hormone periodic treatment such as estradiol valerate for 2 - 4 months.
Under the monitori</description><identifier>ISSN: 0529-567X</identifier><identifier>PMID: 17983489</identifier><language>chi</language><publisher>China</publisher><subject>Abortifacient Agents, Nonsteroidal - administration & dosage ; Abortifacient Agents, Nonsteroidal - therapeutic use ; Adult ; Chorionic Gonadotropin, beta Subunit, Human - blood ; Combined Modality Therapy ; Electrosurgery - methods ; Female ; Humans ; Hysteroscopy - methods ; Methotrexate - administration & dosage ; Methotrexate - therapeutic use ; Mifepristone - administration & dosage ; Mifepristone - therapeutic use ; Misoprostol - administration & dosage ; Misoprostol - therapeutic use ; Placenta, Retained - diagnostic imaging ; Placenta, Retained - drug therapy ; Placenta, Retained - surgery ; Pregnancy ; Retrospective Studies ; Treatment Outcome ; Ultrasonography - methods</subject><ispartof>Chung-hua fu chʿan kʿo tsa chih, 2007-08, Vol.42 (8), p.523-525</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17983489$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mu, Yu-lan</creatorcontrib><creatorcontrib>Liu, Ming</creatorcontrib><creatorcontrib>Li, Qiang</creatorcontrib><creatorcontrib>Yang, Zhong-li</creatorcontrib><creatorcontrib>Yin, Fu-bo</creatorcontrib><title>Clinical value of transcervical resection under hysteroscope for placental remnants</title><title>Chung-hua fu chʿan kʿo tsa chih</title><addtitle>Zhonghua Fu Chan Ke Za Zhi</addtitle><description>To study the clinical value of transcervical resection under hysteroscope in treatment of placental remnants.
From March 2003 to April 2006, 14 cases of placental remnants were treated with transcervical resection under hysteroscope. They included 3 cases of term birth, and 11 cases of midtrimester induction of labor. Drug pretreatment was performed for those who had more than 80 U/L of blood beta-human chorionic gonadotropin (beta-hCG) level, including mifepristone (RU486), Chinese herbs and methotrexate (MTX). RU486 was taken orally at 25 mg, three times daily and misoprostol was given 600 microg at one dose on the third day. MTX was given by deep intramuscular injection at 1 mg/m(2) if beta-hCG was higher than 150 U/L. Bipolar evaporation was used in the operation with alternation of resection and forceps holder under ultrasonographic supervision. After operation a circular contraceptive device was placed followed by hormone periodic treatment such as estradiol valerate for 2 - 4 months.
Under the monitori</description><subject>Abortifacient Agents, Nonsteroidal - administration & dosage</subject><subject>Abortifacient Agents, Nonsteroidal - therapeutic use</subject><subject>Adult</subject><subject>Chorionic Gonadotropin, beta Subunit, Human - blood</subject><subject>Combined Modality Therapy</subject><subject>Electrosurgery - methods</subject><subject>Female</subject><subject>Humans</subject><subject>Hysteroscopy - methods</subject><subject>Methotrexate - administration & dosage</subject><subject>Methotrexate - therapeutic use</subject><subject>Mifepristone - administration & dosage</subject><subject>Mifepristone - therapeutic use</subject><subject>Misoprostol - administration & dosage</subject><subject>Misoprostol - therapeutic use</subject><subject>Placenta, Retained - diagnostic imaging</subject><subject>Placenta, Retained - drug therapy</subject><subject>Placenta, Retained - surgery</subject><subject>Pregnancy</subject><subject>Retrospective Studies</subject><subject>Treatment Outcome</subject><subject>Ultrasonography - methods</subject><issn>0529-567X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kEtLAzEYRbNQbKn9C5KVu4HJY_JYSvEFBRcquBvy-AYHMsmYZAr995ZaVxcuh8PlXqF121HddEJ-rdC2lNG2HWFCUaJv0IpIrRhXeo3ed2GMozMBH0xYAKcB12xicZAP5zpDAVfHFPESPWT8fSwVciouzYCHlPEcjINYz-gUTazlFl0PJhTYXnKDPp8eP3Yvzf7t-XX3sG9mQnltVCs77YhzQKxySjJmPdOSSCYo19pzar1wxArdUvAGlKad05QOkg_OG8M26P7PO-f0s0Cp_TSehodgIqSl9EJxRSjlJ_DuAi52At_PeZxMPvb_N7BfDTpazw</recordid><startdate>200708</startdate><enddate>200708</enddate><creator>Mu, Yu-lan</creator><creator>Liu, Ming</creator><creator>Li, Qiang</creator><creator>Yang, Zhong-li</creator><creator>Yin, Fu-bo</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200708</creationdate><title>Clinical value of transcervical resection under hysteroscope for placental remnants</title><author>Mu, Yu-lan ; Liu, Ming ; Li, Qiang ; Yang, Zhong-li ; Yin, Fu-bo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p124t-80759c1cce1b8c8733bd39717362499d42bd6c1b6902edae8925c922f74fcdaa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>chi</language><creationdate>2007</creationdate><topic>Abortifacient Agents, Nonsteroidal - administration & dosage</topic><topic>Abortifacient Agents, Nonsteroidal - therapeutic use</topic><topic>Adult</topic><topic>Chorionic Gonadotropin, beta Subunit, Human - blood</topic><topic>Combined Modality Therapy</topic><topic>Electrosurgery - methods</topic><topic>Female</topic><topic>Humans</topic><topic>Hysteroscopy - methods</topic><topic>Methotrexate - administration & dosage</topic><topic>Methotrexate - therapeutic use</topic><topic>Mifepristone - administration & dosage</topic><topic>Mifepristone - therapeutic use</topic><topic>Misoprostol - administration & dosage</topic><topic>Misoprostol - therapeutic use</topic><topic>Placenta, Retained - diagnostic imaging</topic><topic>Placenta, Retained - drug therapy</topic><topic>Placenta, Retained - surgery</topic><topic>Pregnancy</topic><topic>Retrospective Studies</topic><topic>Treatment Outcome</topic><topic>Ultrasonography - methods</topic><toplevel>online_resources</toplevel><creatorcontrib>Mu, Yu-lan</creatorcontrib><creatorcontrib>Liu, Ming</creatorcontrib><creatorcontrib>Li, Qiang</creatorcontrib><creatorcontrib>Yang, Zhong-li</creatorcontrib><creatorcontrib>Yin, Fu-bo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Chung-hua fu chʿan kʿo tsa chih</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mu, Yu-lan</au><au>Liu, Ming</au><au>Li, Qiang</au><au>Yang, Zhong-li</au><au>Yin, Fu-bo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical value of transcervical resection under hysteroscope for placental remnants</atitle><jtitle>Chung-hua fu chʿan kʿo tsa chih</jtitle><addtitle>Zhonghua Fu Chan Ke Za Zhi</addtitle><date>2007-08</date><risdate>2007</risdate><volume>42</volume><issue>8</issue><spage>523</spage><epage>525</epage><pages>523-525</pages><issn>0529-567X</issn><abstract>To study the clinical value of transcervical resection under hysteroscope in treatment of placental remnants.
From March 2003 to April 2006, 14 cases of placental remnants were treated with transcervical resection under hysteroscope. They included 3 cases of term birth, and 11 cases of midtrimester induction of labor. Drug pretreatment was performed for those who had more than 80 U/L of blood beta-human chorionic gonadotropin (beta-hCG) level, including mifepristone (RU486), Chinese herbs and methotrexate (MTX). RU486 was taken orally at 25 mg, three times daily and misoprostol was given 600 microg at one dose on the third day. MTX was given by deep intramuscular injection at 1 mg/m(2) if beta-hCG was higher than 150 U/L. Bipolar evaporation was used in the operation with alternation of resection and forceps holder under ultrasonographic supervision. After operation a circular contraceptive device was placed followed by hormone periodic treatment such as estradiol valerate for 2 - 4 months.
Under the monitori</abstract><cop>China</cop><pmid>17983489</pmid><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0529-567X |
| ispartof | Chung-hua fu chʿan kʿo tsa chih, 2007-08, Vol.42 (8), p.523-525 |
| issn | 0529-567X |
| language | chi |
| recordid | cdi_proquest_miscellaneous_68481224 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
| subjects | Abortifacient Agents, Nonsteroidal - administration & dosage Abortifacient Agents, Nonsteroidal - therapeutic use Adult Chorionic Gonadotropin, beta Subunit, Human - blood Combined Modality Therapy Electrosurgery - methods Female Humans Hysteroscopy - methods Methotrexate - administration & dosage Methotrexate - therapeutic use Mifepristone - administration & dosage Mifepristone - therapeutic use Misoprostol - administration & dosage Misoprostol - therapeutic use Placenta, Retained - diagnostic imaging Placenta, Retained - drug therapy Placenta, Retained - surgery Pregnancy Retrospective Studies Treatment Outcome Ultrasonography - methods |
| title | Clinical value of transcervical resection under hysteroscope for placental remnants |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T23%3A26%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20value%20of%20transcervical%20resection%20under%20hysteroscope%20for%20placental%20remnants&rft.jtitle=Chung-hua%20fu%20ch%CA%BFan%20k%CA%BFo%20tsa%20chih&rft.au=Mu,%20Yu-lan&rft.date=2007-08&rft.volume=42&rft.issue=8&rft.spage=523&rft.epage=525&rft.pages=523-525&rft.issn=0529-567X&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E68481224%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68481224&rft_id=info:pmid/17983489&rfr_iscdi=true |